Literature DB >> 24737877

Policy Statement on the 340B Drug Pricing Program by the American Society of Clinical Oncology.

.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24737877     DOI： 10.1200/JOP.2014.001432

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  3 in total

1.  The 340B discount program: outpatient prescription dispensing patterns through contract pharmacies in 2012.

Authors:  Bobby L Clark; John Hou; Chia-Hung Chou; Elbert S Huang; Rena Conti
Journal:  Health Aff (Millwood)       Date:  2014-11       Impact factor: 6.301

2.  The unintended consequences of the 340B safety-net drug discount program.

Authors:  Samuel Thomas; Kevin Schulman
Journal:  Health Serv Res       Date:  2020-03-01       Impact factor: 3.402

3.  Economic Evaluation of Changes in Reimbursement for Medications Purchased Through the 340B Drug Pricing Program.

Authors:  Lauren A Endriukaitis; Genevieve L Hayes; Jason Mills
Journal:  Hosp Pharm       Date:  2019-11-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.